Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-24 @ 6:44 PM
NCT ID:
NCT04626557
Eligibility Criteria:
Inclusion criteria:
Asthma n= 15:
* Informed consent.
* Diagnosis of asthma.
* 18-40 years.
* Referred to Intra Uterine Insemination (IUI) or in vitro fertilization (IVF)
Non-asthmatic n= 15:
* Informed consent.
* 18-40 years.
* Referred to Intra Uterine Insemination (IUI) or in vitro fertilization (IVF)
Exclusion criteria:
Asthma only:
* Other respiratory diseases than asthma.
* Other inflammatory disease or a disease that affects fertility.
* Infections requiring antibiotics or anti-viral treatment within 30 days.
* Current smokers and/or life-time tobacco exposure \> 10 pack-years.
* Endometriosis.
* Infertility due to other reasons than male factor, tubal factor or unexplained infertility.
* No pelvic inflammatory disease (PID) within the last 6 months.
* No contraceptive intrauterine device (IUD), or other contraceptive for the last 6 months.
Non-asthmatic controls:
* No respiratory diseases.
* Other inflammatory disease or a disease that affects fertility.
* Infections requiring antibiotics or anti-viral treatment within 30 days.
* Current smokers and/or life-time tobacco exposure \> 10 pack-years.
* Endometriosis.
* Infertility due to other reasons than male factor, tubal factor or unexplained infertility.
* No pelvic inflammatory disease (PID) within the last 6 months.
* No contraceptive intrauterine device (IUD), or other contraceptive for the last 6 months.
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT04626557
Study Brief:
Protocol Section:
NCT04626557